JLABS | Reducing vein-to-vein time for cell therapy

JLABS | Reducing vein-to-vein time for cell therapy

4 December 2025 | 09:00–12:30 CET | Utrecht, the Netherlands (or virtual)

Hosted by Johnson & Johnson, this event explores how automation and real-time analytics can shorten the vein-to-vein timeline in CAR-T cell therapy—enhancing access, reducing costs, and improving patient outcomes.

Speakers from Johnson & Johnson, NecstGen, Cellular Origins, SymCel, and NanoCell Tx will share innovations aimed at streamlining manufacturing, quality control, and scalability in cell and gene therapy.

The session will be held in Utrecht (venue to be confirmed) and can also be attended virtually. Participation can be combined with the Oncode Accelerator Summit at Jaarbeurs Utrecht in the afternoon.

Register here

Testimonials

testimonial

This course offers an opportunity to meet likeminded people, share tips and tricks, and dive into different approaches to help you set up and improve KTO processes.

Brechtje Vreenegoor

Radboud University, Netherlands

testimonial

A lot of fruitful discussions with experienced peers. Very helpful sessions.

Sara Matt-Leubner

University of Innsbruck, Austria

testimonial

The expert-panel discussion educated me in strategic and meritorious choice of inventions to approach investors and manage investment funds for establishing a spin off.  

Ram Siddappa

Erasmus MC, Netherlands

testimonial

This course gives an in-depth understanding on managing contract portfolio, including research contracts, license agreements, and other collaboration agreements.

Ram Siddappa

Erasmus MC, Netherlands

testimonial

I am happy to be able to share my own experiences with other colleagues via various courses, and I enjoy every moment I can spend in this network. Proud to be part of the ASTP community!

Paul van Dun

KU Leuven, Belgium